LAWRENCEVILLE, NJ--(Marketwire - February 29, 2012) - Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced that management will present at the following upcoming investor conferences during the month of March 2012.
Conference: Cowen and Company 32nd Annual Health Care Conference
Date: Wednesday, March 7, 2012 at 8:00 a.m. Eastern time in Boston, MA
Conference: Roth Capital Partners 24th Annual Growth Stock Conference
Date: Tuesday, March 13, 2012 at 8:30 a.m. Pacific time in Dana Point, CA
Conference: Rodman & Renshaw 2nd Annual Life Sciences Summit
Date: Wednesday, March 21 to Friday, March 23, 2012 in Park City, UT
The Rodman & Renshaw Summit will allow institutional investors to meet with management but does not include a formal presentation.
A live audio only webcast of the presentations will be available on Celsion’s website at http://www.celsion.com/events.cfm. The webcast will be archived on the same site for replay following the conference.
About Celsion Corporation
Celsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination with its heat-activated liposomal drug technology. Celsion has research, license, or commercialization agreements with leading institutions such as the National Institutes of Health, Duke University Medical Center, University of Hong Kong, the University of Pisa, the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital.
For more information on Celsion, visit our website: http://www.celsion.com.
Investor Contact
David Pitts
Argot Partners
212-600-1902
Email Contact
